Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease
ABSTRACT Background and Objective Alpha‐synuclein (α‐Syn) is immunohistochemically detectable in enteric neurons in some subjects. We determined its age distribution in the general autopsy population and in an age‐matched subset investigated differences with Parkinson's (PD) and Alzheimer'...
Saved in:
Published in | Movement disorders Vol. 28; no. 2; pp. 237 - 241 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.02.2013
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ABSTRACT
Background and Objective
Alpha‐synuclein (α‐Syn) is immunohistochemically detectable in enteric neurons in some subjects. We determined its age distribution in the general autopsy population and in an age‐matched subset investigated differences with Parkinson's (PD) and Alzheimer's diseases (AD).
Methods
Archival autopsy samples of colon from 95 cases (77 general population, 10 PD, and 8 AD) were immunostained with monoclonal antibody KM51. α‐Syn detectability was semiquantitatively graded 1 to 3.
Results
α‐Syn was detectable in 52% of the general population, and its level of expression did not change between ages 40 and 91. All PD subjects were α‐Syn positive, with higher prevalence (P = 0.001) and grade (P = 0.003) than age‐matched controls. AD subjects were no more likely to be α‐Syn positive or have a higher grade than controls.
Conclusions
Either PD develops selectively in the enterically α‐Syn‐positive population subset or PD induces this expression. Absence of increased α‐Syn expression in AD points to differences in pathogenesis. © 2013 Movement Disorder Society |
---|---|
Bibliography: | ark:/67375/WNG-QS5HGMN9-P istex:ECB885A980B44E5E53A297F492BEB3B7E6F86B64 ArticleID:MDS25298 Full financial disclosures and author roles may be found in the online version of this article. Dr. Munoz has received speaker honoraria from Novartis and Janssen, not related to the research reported here. Relevant Conflicts of Interest/Financial Disclosures Funding agencies This study was funded by the Department of Laboratory Medicine at St. Michael's Hospital (Toronto, Ontario, Canada). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0885-3185 1531-8257 1531-8257 |
DOI: | 10.1002/mds.25298 |